SPER Market Research

Dr. Dinesh Jaiswal brings an unparalleled depth of scientific and organizational leadership to his role as independent director at SPER Market Research®, cultivated through over 40 years of impactful experience in the pharmaceutical industry. His expertise spans the entire spectrum of product development, from formulation and process optimization across various dosage forms to robust analytical development. A testament to his capabilities is his significant contribution to the successful market launch of products like Lexapro, showcasing his ability to translate scientific innovation into tangible market successes.

Beyond his scientific acumen, Dr. Jaiswal excels as an organizational leader and mentor, fostering a learning-centric environment focused on delivering tangible results. His underlying philosophy centers on cultivating "scientist leaders" who possess a strong understanding of both the scientific and business aspects of the pharmaceutical field. His profound understanding of GMP operations, emphasizing organized data management and unwavering rigor, ensured a decade of successful audit inspections without a single observation during his management of a GMP stability organization, a direct result of his strong documentation practices and the process-oriented culture he nurtured.

As a trusted director and counselor on scientific risk management, Dr. Jaiswal demonstrates strong decision-making capabilities grounded in both regulatory guidelines (FDA, EMA, and ICH) and sound scientific rationale. His early adoption of risk management principles underscores his proactive approach to drug product development. With over 30 years of experience in both industry and academia, including significant contributions to bringing key drugs like Linzess and Nemenda to market, Dr. Jaiswal's wealth of knowledge and strategic insights provide invaluable guidance to SPER Market Research® and its clients.